OGEN
ORAGENICS INCCompany Information
- Company Name
- ORAGENICS INC
- CIK
- CIK0001174940
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- OGEN: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- OGEN
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2025-12-12
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 10,464
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 67,532
- Shares outstanding
- 4,428,566
- Ownership
- 1.52%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -3.77%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 6 | 4 | 11 | 2 | 3 | 1 | 3 | 1 | 2 | 3 | 6 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 5 | 7 | 10 | 13 | 2 | 4 | 1 | 4 | 2 | 2 | 4 | 8 | ||||||
| Other Receivables Net Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Short Term Investments | - | - | 4 | - | - | - | - | - | - | - | - | - | ||||||
| Interest Receivable | - | - | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 2 | 1 | 2 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 2 | ||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Prepaid Expense Noncurrent | - | - | - | - | - | - | - | - | - | - | 1 | - | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Deposits Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Assets | 5 | 7 | 10 | 13 | 2 | 4 | 1 | 5 | 3 | 4 | 5 | 8 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | - | - | - | - | - | - | - | - | - | - | 2 | 1 | ||||||
| Notes Payable Current | - | 0 | 0 | 0 | 3 | 3 | 0 | 1 | - | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities | 2 | 1 | 2 | 3 | 4 | 4 | 2 | 2 | 1 | 1 | 2 | - | ||||||
| Preferred Stock Value | - | - | - | - | - | - | - | 2 | 2 | 2 | 2 | 2 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 4 | 6 | 8 | 10 | -2 | 0 | -0 | 3 | 1 | 3 | 3 | 6 | ||||||
| Additional Paid In Capital | 235 | 235 | 235 | 234 | 219 | 219 | 217 | 215 | 211 | 210 | 208 | 198 | ||||||
| Retained Earnings Accumulated Deficit | -231 | -229 | -227 | -224 | -221 | -219 | -217 | -213 | -211 | -209 | -206 | -193 | ||||||
| Liabilities And Stockholders Equity | 5 | 7 | 10 | 13 | 2 | 4 | 1 | 5 | 3 | 4 | 5 | 8 | ||||||
| Preferred Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | 7 | - | - | - | 17 | - | ||||||
| Common Stock Shares Authorized | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 350 | 4 | ||||||
| Common Stock Shares Issued | 5 | 4 | 4 | 4 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 5 | 4 | 4 | 4 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialORAGENICS INC (OGEN) — SEC Financial Statements & Analysis
ORAGENICS INC (OGEN) is a pharmaceutical preparations company, incorporated in FL. ORAGENICS INC trades on NYSE as: OGEN. ORAGENICS INC (OGEN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, ORAGENICS INC carries a market cap of $2.57M, a P/E ratio of -0.25x, a P/B ratio of 0.70x, a P/S ratio of 630.89x, an enterprise value of $-1.30M, and an EV/EBITDA multiple of 0.12x. On profitability, it posts an operating margin of -263285.20%, a net margin of -261401.51%, a Return on Equity (ROE) of -1307.06%, a Return on Assets (ROA) of -264.23%, and a Return on Invested Capital (ROIC) of -557.15%. Per share, it reports EPS of $-2.28, diluted EPS of $-2.28, free cash flow per share of $-2.30, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -2.11% year-over-year, and EPS growth of -83.82% year-over-year. On the balance sheet, it maintains a current ratio of 2.15x, a quick ratio of 1.94x, working capital of $2.07M, a debt-to-equity ratio of 0.57x, a debt ratio of 0.36, an interest coverage ratio of -561.90x, free cash flow of $-10.21M (TTM), and net debt of $-3.86M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.57M
- P/E TTM
- -0.25x
- EPS TTM
- $-2.28
- P/B TTM
- 0.70x
- ROE TTM
- -1307.06%
- ROA TTM
- -264.23%
- Debt To Equity
- 0.57x
- Free Cash Flow TTM
- $-10.21M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ORAGENICS INC in?
ORAGENICS INC (OGEN) operates in the Pharmaceutical Preparations industry.
What exchange does OGEN trade on?
ORAGENICS INC (OGEN) trades on the NYSE.
Where is ORAGENICS INC incorporated?
ORAGENICS INC is incorporated in FL.
When was ORAGENICS INC (OGEN)'s most recent SEC filing?
ORAGENICS INC (OGEN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is OGEN's market cap?
ORAGENICS INC (OGEN) has a market capitalization of $2.57M as of 2026-06-30.
What is OGEN's EPS (earnings per share)?
ORAGENICS INC (OGEN)'s trailing twelve month EPS is $-2.28 as of 2026-06-30.
What is OGEN's ROE (return on equity)?
ORAGENICS INC (OGEN)'s trailing twelve month Return on Equity (ROE) is -1307.06% as of 2026-06-30.
What is OGEN's ROA (return on assets)?
ORAGENICS INC (OGEN)'s trailing twelve month Return on Assets (ROA) is -264.23% as of 2026-06-30.
What is OGEN's ROIC (return on invested capital)?
ORAGENICS INC (OGEN)'s trailing twelve month Return on Invested Capital (ROIC) is -557.15% as of 2025-12-31.
What is OGEN's EV/EBITDA?
ORAGENICS INC (OGEN)'s trailing twelve month EV/EBITDA is 0.12x as of 2026-06-30.